A Rational Computational Pipeline for the Discovery of a Potent EGF-Mimetic Ligand with In vitro Enhanced Proliferative Activity in Cancer Stem Cells

Journal of Analysis and Testing · Springer Nature · 2026-11-05 · DOI: 10.1007/s12010-026-05903-7

Аннотация

This study developed a novel synthetic biomimetic ligand that replicates Epidermal Growth Factor (EGF) using an integrated in silico and in vitro pipeline. A fragment-based design strategy generated a virtual library, which was filtered to identify drug-like compounds with high predicted affinity for the EGFR. The lead compound, DB09210, demonstrated exceptional biomimetic properties. In human fibroblasts, it sustained cell viability comparably to fetal bovine serum. Notably, in 3D cultures of gastric cancer stem cells (GCSCs), DB09210 exhibited potent, time- and dose-dependent activity, surpassing native EGF in promoting proliferation after 7 days. The observed maintenance of CD133 + expression can be interpreted as evidence for preserved stemness, implying the compound may act as a potent functional mimetic mechanism. While its potent enrichment of cancer stem cells requires therapeutic caution, DB09210 is a powerful tool compound. Its ability to reliably expand stem cell populations under defined, serum-free conditions holds significant promise for regenerative medicine, organoid biobanking, and advanced ex vivo drug screening platforms.

Читать у издателя →

Похожие статьи